Matching slides 41,369
Current window 31,111-31,140
Pages 1,379
Rows per page 30
Component: Calloutclear collectionreset all

Component

31,111-31,140 of 41,369

filter-aware
17
The slide uses a three-row layout to contrast the problem, current limitations, and the proposed solution.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
18
Slide 18 of the deck.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
Includes a testimonial/quote from a partner at the bottom.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
29
Includes specific clinical data points from a Postcoital Test (PCT) study.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
33
The slide uses a bulleted list to define the product profile and concludes with a strong market gap statement regarding FSAD.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
37
Study design is a small N=6 crossover trial.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
38
Dare Bioscience | Investor Presentation Deck | 50 slidesDare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
43
The slide highlights the clinical need for a long-acting progesterone delivery system for preterm birth prevention and IVF support.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
44
The slide highlights the regulatory pathway (505(b)(2)) and the specific patient population (HR+ breast cancer survivors).Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
47
The slide uses a comparative structure to frame the problem (limitations of current standard) and the solution (target product profile).Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
48
The slide outlines a development roadmap with specific milestones and associated funding amounts.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
49
The slide uses a callout box to highlight the mechanism of action and clinical potential of GML.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
20
The slide uses a visual comparison of star ratings and numerical scores for various music streaming services.Deezer | Investor Day Presentation Deck | 93 slides · Deezer
Conference presentation Investor relations 1 hit
64
The slide uses a specific highlight on the 16-24 age group to emphasize the +55% conversion potential compared to other age groups.Deezer | Investor Day Presentation Deck | 93 slides · Deezer
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
65
The slide combines strategic acquisition details with performance metrics from a specific event (Little Mix) to validate the business case.Deezer | Investor Day Presentation Deck | 93 slides · Deezer
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
76
Deezer | Investor Day Presentation Deck | 93 slidesDeezer | Investor Day Presentation Deck | 93 slides · Deezer
Conference presentation Investor relations 1 hit
91
Includes a table of share classes and a pie chart of shareholder ownership.Deezer | Investor Day Presentation Deck | 93 slides · Deezer
Conference presentation Investor relations 1 hit
04
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
07
The diagram uses a branching logic to show how core pipelines lead to multiple indications/products, which then feed into a value-maximization arrow.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
20
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
27
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
19
Includes callouts for COVID-19 impact and management guidance on 3-year average differentials.Evercore | Investment Banking Pitch Book | 61 slides · Evercore
Consulting deck Investment bank Beat · Evidence & Proof1 hit
23
The chart uses a floating bar (waterfall-style) representation to show valuation ranges across different methodologies.Evercore | Investment Banking Pitch Book | 61 slides · Evercore
Consulting deck Investment bank Beat · Evidence & Proof1 hit
24
The slide uses a football field chart to visualize valuation ranges. The proposed consideration of $19.00 is marked as a horizontal reference line.Evercore | Investment Banking Pitch Book | 61 slides · Evercore
Consulting deck Investment bank Beat · Evidence & Proof1 hit
25
The chart uses a dashed line to represent the proposed consideration of $19.00 across all valuation methods.Evercore | Investment Banking Pitch Book | 61 slides · Evercore
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
35
The slide provides a benchmark for transaction premiums in the midstream energy sector.Evercore | Investment Banking Pitch Book | 61 slides · Evercore
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
60
Includes a disclaimer about the source of the data and the methodology behind the pricing differences.Evercore | Investment Banking Pitch Book | 61 slides · Evercore
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
61
Includes a specific Evercore note regarding management's view on the provided data.Evercore | Investment Banking Pitch Book | 61 slides · Evercore
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
04
The chart includes a callout explaining a data gap in 2Q20 due to COVID-19.Evercore | Investment Banking Pitch Book | 9 slides · Evercore
Consulting deck Investment bank Beat · Evidence & ProofLoop · Zoom In1 hit
07
The chart uses a floating bar format to show valuation ranges for different financial scenarios.Evercore | Investment Banking Pitch Book | 9 slides · Evercore
Consulting deck Investment bank Beat · Solution & ApproachLoop · Hypothesis Test1 hit